BE820360A - Compositions pour le traitement de l'helminthiase - Google Patents

Compositions pour le traitement de l'helminthiase

Info

Publication number
BE820360A
BE820360A BE148912A BE148912A BE820360A BE 820360 A BE820360 A BE 820360A BE 148912 A BE148912 A BE 148912A BE 148912 A BE148912 A BE 148912A BE 820360 A BE820360 A BE 820360A
Authority
BE
Belgium
Prior art keywords
helminthiase
compositions
treatment
Prior art date
Application number
BE148912A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE820360A publication Critical patent/BE820360A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • A61K31/625Salicylic acid; Derivatives thereof having heterocyclic substituents, e.g. 4-salicycloylmorpholine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/58Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE148912A 1973-09-27 1974-09-26 Compositions pour le traitement de l'helminthiase BE820360A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/401,499 US3956488A (en) 1973-09-27 1973-09-27 Compositions and methods for the treatment of helminthiasis

Publications (1)

Publication Number Publication Date
BE820360A true BE820360A (fr) 1975-03-26

Family

ID=23588009

Family Applications (1)

Application Number Title Priority Date Filing Date
BE148912A BE820360A (fr) 1973-09-27 1974-09-26 Compositions pour le traitement de l'helminthiase

Country Status (6)

Country Link
US (1) US3956488A (fr)
BE (1) BE820360A (fr)
DE (1) DE2446105A1 (fr)
FR (1) FR2245368B1 (fr)
GB (1) GB1449945A (fr)
NL (1) NL7411955A (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE48627B1 (en) * 1978-09-11 1985-04-03 Ici Tasman Ltd Injectable composition for the treatment,of helminthiasis and clostridial diseases in animals

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3646049A (en) * 1970-03-05 1972-02-29 Merck & Co Inc Acylaminobenzimidazole derivatives
US3798258A (en) * 1970-03-13 1974-03-19 Merck & Co Inc Salicylanilides

Also Published As

Publication number Publication date
US3956488A (en) 1976-05-11
FR2245368B1 (fr) 1978-06-30
FR2245368A1 (fr) 1975-04-25
DE2446105A1 (de) 1975-04-03
AU7336774A (en) 1976-03-25
GB1449945A (en) 1976-09-15
NL7411955A (nl) 1975-04-02

Similar Documents

Publication Publication Date Title
BE822770A (fr) Composition pour le traitement de la diarrhee
BE824782A (fr) Compositions pour le traitement de gingivite
BE851328A (fr) Composition pour le traitement de l'hypercholesterolemie
BE859817A (fr) Compositions notamment utiles pour le traitement de l'acne
RO64359A (fr) Procede pour la preparation d'une composition antiseptique
BE843359A (fr) Preparation pour le traitement de parodontose
BE849416A (fr) Composition anti-moussage pour le traitement de denrees alimentaires
BE812907A (fr) Compositions pour le traitement de la diarrhee
BE807080A (fr) Compositions pour le traitement de surfaces
BE828555A (fr) Composition pour le traitement d'infections virales
BE840614A (fr) Compositions pour le traitement des etoffes
BE811068A (fr) Composition pour le traitement des cheveux
BE793792A (fr) Compositions pour le traitement de la peau
FR2306710A1 (fr) Composition pour le traitement du colon
BE851775A (fr) Composition pour le traitement de la chevelure
BE873092A (fr) Composition pour le traitement de l'hypertension
BE885291A (fr) Compositions pharmaceutiques pour le traitement des dysfonctionnements cardiaques
BE858692A (fr) Composition pour le traitement de l'acne
BE872908A (fr) Compositions pharmaceutiques pour le traitement de l'hypertension
FR2340737A1 (fr) Composition pour le traitement de l'hypercholesterolemie
BE815825A (fr) Composition pour le traitement de la peau
BE815397A (fr) Conposes pour le traitement de tumeurs calciques
BE842389A (fr) Composition pharmaceutique pour le traitement de l'hyperuricemie
BE751792A (fr) Composes efficaces pour le traitement d'etats bronchospastique
BE820360A (fr) Compositions pour le traitement de l'helminthiase

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: MERCK & CO. INC.

Effective date: 19850930